# HUTCHMED (China) Ltd: Form 20-F for the period ended Dec 31, 2020

- Company: [HUTCHMED (China) Ltd](/companies/hcm.md) (CIK 1648257)
- Form: 20-F
- Filed: 2021-03-04
- Accepted by EDGAR: Mar 4, 2021, 09:11 ET
- Period: 2020-12-31
- Accession: 0001104659-21-031897
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1648257/000110465921031897/hcm-20201231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1648257/000110465921031897/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2020-01-01 to 2020-12-31 | $228.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 12 months, 2020-01-01 to 2020-12-31 | $174.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2020-01-01 to 2020-12-31 | −$196.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2020-01-01 to 2020-12-31 | $787.0k | us-gaap:InterestExpense |
| Income tax | 12 months, 2020-01-01 to 2020-12-31 | $4.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2020-01-01 to 2020-12-31 | −$125.7m | us-gaap:NetIncomeLoss |
| Basic EPS | 12 months, 2020-01-01 to 2020-12-31 | −$0.18 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 12 months, 2020-01-01 to 2020-12-31 | −$62.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2020-01-01 to 2020-12-31 | $7.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months, 2020-01-01 to 2020-12-31 | $12.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-12-31 | $235.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-12-31 | $530.7m | us-gaap:AssetsCurrent |
| Total assets | at 2020-12-31 | $724.1m | us-gaap:Assets |
| Current liabilities | at 2020-12-31 | $158.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-12-31 | $205.2m | us-gaap:Liabilities |
| Long-term debt | at 2020-12-31 | $26.9m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2020-12-31 | $484.1m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2020-12-31 | 727,722,215 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1648257/000110465921031897/hcm-20201231x20f.htm

Filed Mar 4, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-031897. Last ingested by Listed: Nov 5, 2026, 11:21 ET. No prices; not investment advice.